Drugmakers Face Rising Costs to Prepare for ‘No Deal’ Brexit

December 5, 2018

U.K.-based drug companies face mounting costs in preparing for the U.K. to leave the E.U. without any trading arrangements, they said at a Nov. 28 parliamentary hearing.

Related Stories